HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

6-Gingerol as an arginase inhibitor prevents urethane-induced lung carcinogenesis by reprogramming tumor supporting M2 macrophages to M1 phenotype.

Abstract
6-Gingerol (6-G) is the main bioactive component in Ginger (Zingiber officinale Roscoe). The aim of this study was to explore the contribution of macrophage polarization in 6-G-associated anti-cancer effects. In a urethane-induced lung carcinogenic model, lung carcinogenesis was positively correlated with macrophage (F4/80+) infiltration in lung interstitial in the control group. Furthermore, higher numbers of arginase+/F4/80+ M2 cells than iNOS+/F4/80+ M1 cells were observed in interstitial macrophages. Moreover, macrophage depletion by liposome-encapsulated clodronate (LEC) could significantly prevent lung carcinogenesis, whereas pexidartinib promoted lung carcinogenesis. After 6-G treatment, lung carcinogenesis was ameliorated with increased M1 macrophages and decreased M2 macrophages in the lung interstitial. ELISA showed that the levels of IFN-γ and IL-12 increased and the levels of IL-10 and TGF-β1 decreased in the alveolar cavity compared to those in the control group. Unexpectedly, the carcinogenesis-preventing efficacy of 6-G was promoted in LEC-treated mice, but completely aborted in pexidartinib-treated mice. In the in vitro experiment, 6-G reset the IL-4-induced arginase+ M2 cells toward iNOS+ M1 cells and exhibited reduced levels of arginase 1 and ROS and elevated levels of L-arginine and NO. LEC and nor-NOHA selectively suppressed M2 macrophages but had a negligible effect on M1 macrophages, whereas pexidartinib decreased both M2 and M1 macrophages. The iNOS+ macrophage-promoting efficacy of 6-G was increased by LEC, but was completely eliminated by pretreatment with pexidartinib or nor-NOHA. M2 macrophage-resetting efficacy of 6-G was confirmed in a Lewis lung cancer allograft model. This study indicated a reprogramming effect of 6-G as an arginase inhibitor on tumor supporting macrophages.
AuthorsJingjing Yao , Zhenhua Du , Zibo Li , Shuhui Zhang , Yukun Lin , Haiyun Li , Lin Zhou , Yuehua Wang , Guixi Yan , Xianchuang Wu , Yongjian Duan , Gangjun Du
JournalFood & function (Food Funct) Vol. 9 Issue 9 Pg. 4611-4620 (Sep 19 2018) ISSN: 2042-650X [Electronic] England
PMID30151521 (Publication Type: Journal Article)
Chemical References
  • Catechols
  • Enzyme Inhibitors
  • Fatty Alcohols
  • Reactive Oxygen Species
  • Interleukin-10
  • Interleukin-12
  • Urethane
  • gingerol
  • Nitric Oxide Synthase Type II
  • Arginase
Topics
  • Animals
  • Arginase (antagonists & inhibitors, genetics, immunology)
  • Catechols (administration & dosage)
  • Enzyme Inhibitors (administration & dosage)
  • Fatty Alcohols (administration & dosage)
  • Female
  • Humans
  • Interleukin-10 (genetics, immunology)
  • Interleukin-12 (genetics, immunology)
  • Lung (drug effects, immunology, pathology)
  • Lung Neoplasms (chemically induced, enzymology, immunology, prevention & control)
  • Macrophages (drug effects, immunology)
  • Mice
  • Mice, Inbred ICR
  • Nitric Oxide Synthase Type II (genetics, immunology)
  • Reactive Oxygen Species (immunology)
  • Urethane (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: